NCBI PubMed Central
open access
Impact of China's national drug price negotiation on pharmaceutical firms' innovation activities.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pharmaceutical Profits and the Social Value of Innovation#21699
- Reconstructing the professional role of pharmacists in China from the perspective of public value theory: challenges and institutional pathways.#15242
- Pharmaceutical Public-Private Partnerships in the United States and Europe: Moving from the Bench to the Bedside#271038
- Pricing and Reimbursement in U.S. Pharmaceutical Markets#485686
- Turkey - Certain Measures Concerning the Production, Importation and Marketing of Pharmaceutical Products, WT/DS583/ARB25#359277
Record · ID 228032
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive